ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel

June 4, 1999

Letter: Legal Fund Seeks Support For Fisher

March 3, 1995

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

Ad Council, ACS Begin Ad Campaign To Promote Colon Cancer Screening.

February 1, 2002

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

May 27, 2011